Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.

CONCLUSION: NCRT is not sufficient as a stand-alone therapy to eradicate LLN metastasis in lower rectal cancer patients and surgeons should consider performing selective LLND in patients with greater LLN SA diameter, poorer histological differentiation, or advanced T stage. Selective LLND for NCRT patients can have a favorable oncological outcome.
PMID: 32550762 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - June 6, 2020 Category: Gastroenterology Authors: Chen JN, Liu Z, Wang ZJ, Mei SW, Shen HY, Li J, Pei W, Wang Z, Wang XS, Yu J, Liu Q Tags: World J Gastroenterol Source Type: research